PortfoliosLab logo

ProShares UltraShort Nasdaq Biotechnology (BIS)

ETF · Currency in USD · Last updated Aug 13, 2022

BIS is a passive ETF by ProShares tracking the investment results of the NASDAQ Biotechnology Index (-200%). BIS launched on Apr 7, 2010 and has a 0.95% expense ratio.

ETF Info

ISINUS74347B7890
CUSIP74347G838
IssuerProShares
Inception DateApr 7, 2010
RegionNorth America (U.S.)
CategoryLeveraged Equities, Leveraged
Leveraged2x
Expense Ratio0.95%
Index TrackedNASDAQ Biotechnology Index (-200%)
ETF Home Pagewww.proshares.com
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Trading Data

Previous Close$20.90
Year Range$15.86 - $34.96
EMA (50)$24.82
EMA (200)$24.01
Average Volume$39.83K

BISShare Price Chart


Chart placeholderClick Calculate to get results

BISPerformance

The chart shows the growth of $10,000 invested in ProShares UltraShort Nasdaq Biotechnology in Apr 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $44 for a total return of roughly -99.56%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%MarchAprilMayJuneJulyAugust
-16.98%
-4.35%
BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (^GSPC)

BISReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-13.35%12.08%
6M-17.13%-4.97%
YTD4.14%-10.20%
1Y19.63%-3.65%
5Y-26.34%11.89%
10Y-34.71%11.17%

BISMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202225.56%7.14%-10.70%20.24%-1.72%-5.41%-8.68%-15.08%
2021-12.49%3.74%5.47%-6.61%2.85%-15.06%-0.60%-9.57%9.13%3.33%7.24%0.40%
202012.02%-2.33%-3.66%-27.80%-16.70%-5.19%1.62%-2.94%-2.35%5.67%-20.59%-9.43%
2019-23.59%-5.78%0.75%9.71%12.18%-16.59%5.99%4.48%6.55%-14.24%-20.15%-1.95%
2018-13.42%9.48%1.15%4.64%-9.27%-2.99%-11.76%-9.20%0.30%33.27%-10.13%23.71%
2017-10.20%-12.73%1.42%-3.06%7.49%-16.29%-6.02%-9.47%-0.29%12.20%-1.39%-3.16%
201653.67%7.16%-7.87%-7.92%-10.12%15.42%-22.35%5.01%-6.81%24.89%-16.03%5.52%
2015-12.24%-9.86%-5.19%4.09%-17.21%-3.40%-8.50%20.78%21.46%-16.42%-6.70%-4.49%
2014-16.38%-15.18%21.72%1.63%-9.28%-13.33%2.88%-18.29%0.58%-16.94%-5.76%-2.38%
2013-11.96%-4.37%-14.15%-15.56%-9.44%3.36%-24.21%4.12%-14.68%1.84%-17.34%-3.92%
2012-19.26%-6.00%-7.44%-4.45%2.10%-11.36%-8.49%-2.32%-10.11%15.96%-11.75%1.84%
2011-1.30%-1.95%-11.72%-14.35%-2.82%3.58%4.45%6.70%4.58%-12.84%-9.13%-5.62%
2010-0.87%22.49%7.81%-10.18%3.83%-17.86%-8.00%2.03%-11.33%

BISSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ProShares UltraShort Nasdaq Biotechnology Sharpe ratio is 0.39. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-0.500.000.501.001.50MarchAprilMayJuneJulyAugust
0.39
-0.20
BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (^GSPC)

BISDividend History

ProShares UltraShort Nasdaq Biotechnology granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


PeriodTTM202120202019201820172016201520142013201220112010
Dividend$0.00$0.00$0.10$1.13$0.34$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

Dividend yield

0.00%0.00%0.44%2.11%0.38%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

BISDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-99.68%
-10.77%
BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (^GSPC)

BISWorst Drawdowns

The table below shows the maximum drawdowns of the ProShares UltraShort Nasdaq Biotechnology. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ProShares UltraShort Nasdaq Biotechnology is 99.76%, recorded on Sep 2, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.76%Jul 7, 20102717Sep 2, 2021
-13.04%Jun 10, 20103Jun 15, 20109Jul 1, 201012
-11.83%May 7, 20104May 12, 20105May 20, 20109
-9.45%May 27, 20104Jun 3, 20102Jun 8, 20106
-6.59%Apr 28, 20102Apr 29, 20104May 5, 20106
-2.89%Apr 9, 20105Apr 15, 20104Apr 21, 20109
-1.87%Apr 23, 20101Apr 23, 20102Apr 27, 20103
-1.43%Jul 2, 20101Jul 2, 20101Jul 6, 20102

BISVolatility Chart

Current ProShares UltraShort Nasdaq Biotechnology volatility is 58.75%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%MarchAprilMayJuneJulyAugust
58.75%
16.68%
BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (^GSPC)